IGC Pharma (IGC) Interest Coverage Ratio (2010 - 2017)
IGC Pharma's (IGC) quarterly Interest Coverage Ratio came in at 7.81 in Q4 2017, up 5.96% year-over-year from 7.38 in Q4 2016, and down 21.33% quarter-over-quarter from 6.44 in Q3 2017.
Powered by 
Analysis
IGC Pharma (IGC) Interest Coverage Ratio (2010 - 2017) Analysis & Trends
IGC Pharma (IGC) has reported Interest Coverage Ratio for 8 consecutive years, with 7.81 the latest figure, recorded in Q4 2017.
- On a quarterly basis, Interest Coverage Ratio rose 5.96% year-over-year to 7.81 in Q4 2017; TTM through Dec 2017 was 8.02, a 53.53% increase from a year earlier, with the FY2017 full-year figure at 9.19, up 32.32% from the prior year.
- Interest Coverage Ratio was 7.81 for Q4 2017 at IGC Pharma, down from 6.44 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 2.33 in Q2 2013 and troughed at 52.04 in Q1 2016.
- A 5-year average of 11.71 and a median of 7.94 in 2014 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 87.35% in 2013 and sank 708.49% in 2014, its largest moves.
- Over 5 years, Interest Coverage Ratio stood at 5.6 in 2013, then sank by 43.86% to 8.06 in 2014, then increased by 8.73% to 7.35 in 2015, then retreated by 13.01% to 8.31 in 2016, then gained by 5.96% to 7.81 in 2017.
- The last three Interest Coverage Ratio figures came in at 7.81 (Q4 2017), 6.44 (Q3 2017), and 8.9 (Q2 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -7.81 |
| Sep 30, 2017 | -6.44 |
| Jun 30, 2017 | -8.90 |
| Mar 31, 2017 | -8.45 |
| Dec 31, 2016 | -8.31 |
| Sep 30, 2016 | -10.69 |
| Jun 30, 2016 | -7.37 |
| Mar 31, 2016 | -52.04 |
| Dec 31, 2015 | -7.35 |
| Sep 30, 2015 | -7.53 |
| Jun 30, 2015 | -4.16 |
| Mar 31, 2015 | -23.10 |
| Dec 31, 2014 | -8.06 |
| Sep 30, 2014 | -9.60 |
| Jun 30, 2014 | -18.80 |
| Mar 31, 2014 | -26.53 |
| Dec 31, 2013 | -5.60 |
| Sep 30, 2013 | -6.29 |
| Jun 30, 2013 | -2.33 |
| Mar 31, 2013 | -4.76 |